Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs.

Creative Commons License

KESKİN Y., Nas K., Kilic E., Sargin B., Kasman S. A., Alkan H., ...More

Archives of rheumatology, vol.36, no.1, pp.1-9, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.46497/archrheumatol.2021.7874
  • Journal Name: Archives of rheumatology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-9
  • Keywords: Disease-modifying antirheumatic drug, functional status, psoriatic arthritis, quality of life, ANKYLOSING-SPONDYLITIS, RECOMMENDATIONS, BATH, METHOTREXATE, PREVALENCE, INSTRUMENT, MANAGEMENT, ENTHESITIS, THERAPY, BURDEN
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objectives: This study aims to compare the clinical characteristics, disease activity, and quality of life (QoL) of patients with psoriatic arthritis (PsA) who use biological and conventional synthetic disease-modifying antirheumatic drugs (DMARDs) in a nationwide cohort throughout Turkey.